跳至主要内容
临床试验/NCT00914212
NCT00914212已完成1 期

A Functional Magnetic Resonance Imaging (fMRI) Study of the Reproducibility and the Effect of Sibutramine During Fasted and Fed Conditions in Healthy Overweight and Obese Men

Merck Sharp & Dohme LLC0 个研究点目标入组 15 人开始时间: 2009年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
15
主要终点
Average percent signal change of the top 20% of activated voxels (AvgPSC20) during the fasted condition over six primary brain regions of interest (ROI)

研究概览

简要总结

This study will determine whether BOLD-fMRI can be used to probe hunger and satiety states in healthy overweight or obese men and also whether fasted/fed fMRI signals can be modulated by sibutramine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Diagnostic
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Subject is a male between 18 and 45 years of age
  • Subject has a body mass index (BMI) between 28 and 35 kg/m^2
  • Subject does not weigh more than 140 kg (309 lbs) at the screening visit
  • Subject is right-handed
  • Subject is a non-smoker
  • Subject is in generally good health
  • Subject has normal or corrected to normal vision

排除标准

  • Subject works a night shift within 3 days of each treatment visit
  • Subject has permanent cosmetic or metallic objects in his body
  • Subject has attention deficit hyperactivity disorder (ADHD)
  • Subject has or had sleep apnea
  • Subject has a history of neurological disorders
  • Subject has a history of any clinically significant disease or condition
  • Subject is vegan or vegetarian
  • Subject has a history of eating disorders
  • Subject has had previous bariatric surgery

研究组 & 干预措施

2

Placebo Comparator

Placebo

干预措施: Placebo (Drug)

结局指标

主要结局

Average percent signal change of the top 20% of activated voxels (AvgPSC20) during the fasted condition over six primary brain regions of interest (ROI)

时间窗: Day 1

次要结局

  • Test-retest reliability of rCBF in the six ROIs during the fasted and fed states in men receiving placebo(Day 1)
  • Difference in PSC20 during fasted and fed conditions with placebo or sibutramine in the six ROIs(Day 1)
  • Difference in rCBF during fasted and fed conditions with placebo or sibutramine in the six ROIs(Day 1)
  • Intraclass coefficient of correlation of the AvgPSC20 assessed during the fed and fasted conditions over the six ROIs(Day 1)
  • AvgPSC20 in the fed condition with placebo or sibutramine in the six ROIs(Day 1)
  • Regional cerebral blood flow (rCBF) during the fasted condition with placebo or sibutramine in the six ROIs(Day 1)
  • rCBF during the fed condition with placebo or sibutramine in the six ROIs(Day 1)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

A Functional Magnetic Resonance Imaging (fMRI) Study... | 临床试验